Kikuchi Masataka, Ogishima Soichi, Mizuno Satoshi, Miyashita Akinori, Kuwano Ryozo, Nakaya Jun, Tanaka Hiroshi
Department of Molecular Genetics, Center for Bioresources, Brain Research Institute, Niigata University, Niigata, 951-8585, Japan.
Methods Mol Biol. 2016;1303:479-91. doi: 10.1007/978-1-4939-2627-5_29.
Alzheimer's disease (AD) is known to be a multifactorial neurodegenerative disorder, and is one of the main causes of dementia in the elderly. Many studies have demonstrated molecules involved in the pathogenesis of AD, however its underlying mechanisms remain obscure. It may be simplistic to try to explain the disease based on the role of a few genes only. Accumulating new, huge amount of information from e.g. genome, proteome and interactome datasets and new knowledge, we are now able to clarify and characterize diseases essentially as a result of dysfunction of molecular networks. Recent studies have indicated that relevant genes affected in human diseases concentrate in a part of the network, often called as "disease module." In the case of AD, some disease-associated pathways seem different, but some of them are clearly disease-related and coherent. This suggests the existence of a common pathway that negatively drives from healthy state to disease state (i.e., the disease module(s)). Additionally, such disease modules should dynamically change through AD progression. Thus, network-level approaches are indispensable to address unknown mechanisms of AD. In this chapter, we introduce network strategies using gene co-expression and protein interaction networks.
阿尔茨海默病(AD)是一种多因素神经退行性疾病,是老年人痴呆的主要原因之一。许多研究已经证明了参与AD发病机制的分子,但其潜在机制仍不清楚。仅基于少数基因的作用来解释这种疾病可能过于简单。从例如基因组、蛋白质组和相互作用组数据集以及新知识中积累的大量新信息,使我们现在能够将疾病本质上阐明和表征为分子网络功能障碍的结果。最近的研究表明,人类疾病中受影响的相关基因集中在网络的一部分,通常称为“疾病模块”。在AD的情况下,一些与疾病相关的途径似乎不同,但其中一些显然与疾病相关且连贯。这表明存在一条从健康状态向疾病状态负面驱动的共同途径(即疾病模块)。此外,这种疾病模块应随着AD的进展而动态变化。因此,网络层面的方法对于解决AD的未知机制是必不可少的。在本章中,我们介绍使用基因共表达和蛋白质相互作用网络的网络策略。